FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080523033> ?p ?o ?g. }

• W2080523033 abstract "Developing novel drugs from traditional medicinal knowledge can serve as a means to improve public health. Yet countries in sub-Saharan Africa face barriers in translating traditional medicinal knowledge into commercially viable health products. Barriers in moving along the road towards making a new drug available include insufficient manufacturing capacity; knowledge sharing between scientists and medical healers; regulatory hurdles; quality control issues; pricing and distribution; and lack of financing. The case study method was used to illustrate efforts to overcome these barriers during the development in Nigeria of Niprisan - a novel drug for the treatment of sickle cell anemia, a chronic blood disorder with few effective therapies.Building on the knowledge of a traditional medicine practitioner, Nigeria's National Institute for Pharmaceutical Research and Development (NIPRD) developed the traditional herbal medicine Niprisan. The commercialization of Niprisan reached a number of commercial milestones, including regulatory approval in Nigeria; securing US-based commercial partner XeChem; demonstrating clinical efficacy and safety; being awarded orphan drug status by the US Food and Drug Administration; and striking important relationships with domestic and international groups. Despite these successes, however, XeChem did not achieve mainstream success for Niprisan in Nigeria or in the United States. A number of reasons, including inconsistent funding and manufacturing and management challenges, have been put forth to explain Niprisan's commercial demise. As of this writing, NIPRD is considering options for another commercial partner to take the drug forward.Evidence from the Niprisan experience suggests that establishing benefit-sharing agreements, fostering partnerships with established research institutions, improving standardization and quality control, ensuring financial and managerial due diligence, and recruiting entrepreneurial leaders capable of holding dual scientific and business responsibilities should be incorporated into future drug development initiatives based on traditional medicines. Country-level supporting policies and conditions are also important. With more experience and support, and an improved environment for innovation, developing new drugs from traditional medicines may be an attractive approach to addressing diseases in sub-Saharan Africa and other regions." @default.
• W2080523033 created "2016-06-24" @default.
• W2080523033 creator A5039274246 @default.
• W2080523033 creator A5046010426 @default.
• W2080523033 creator A5053698604 @default.
• W2080523033 creator A5058271076 @default.
• W2080523033 creator A5063117834 @default.
• W2080523033 creator A5085801546 @default.
• W2080523033 date "2010-12-01" @default.
• W2080523033 modified "2023-09-27" @default.
• W2080523033 title "The road to commercialization in Africa: lessons from developing the sickle-cell drug Niprisan" @default.
• W2080523033 cites W149190063 @default.
• W2080523033 cites W1966994295 @default.
• W2080523033 cites W1971790908 @default.
• W2080523033 cites W1975364175 @default.
• W2080523033 cites W1984531810 @default.
• W2080523033 cites W1998427422 @default.
• W2080523033 cites W2004901114 @default.
• W2080523033 cites W2005586323 @default.
• W2080523033 cites W2019467629 @default.
• W2080523033 cites W2037256135 @default.
• W2080523033 cites W2038170842 @default.
• W2080523033 cites W2072450555 @default.
• W2080523033 cites W2087870568 @default.
• W2080523033 cites W2099735999 @default.
• W2080523033 cites W2112910792 @default.
• W2080523033 cites W2114086946 @default.
• W2080523033 cites W2147182596 @default.
• W2080523033 cites W2149202606 @default.
• W2080523033 cites W2152355077 @default.
• W2080523033 cites W2161191663 @default.
• W2080523033 doi "https://doi.org/10.1186/1472-698x-10-s1-s11" @default.
• W2080523033 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3001608" @default.
• W2080523033 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21144071" @default.
• W2080523033 hasPublicationYear "2010" @default.
• W2080523033 type Work @default.
• W2080523033 sameAs 2080523033 @default.
• W2080523033 citedByCount "12" @default.
• W2080523033 countsByYear W20805230332012 @default.
• W2080523033 countsByYear W20805230332013 @default.
• W2080523033 countsByYear W20805230332015 @default.
• W2080523033 countsByYear W20805230332016 @default.
• W2080523033 countsByYear W20805230332018 @default.
• W2080523033 countsByYear W20805230332022 @default.
• W2080523033 countsByYear W20805230332023 @default.
• W2080523033 crossrefType "journal-article" @default.
• W2080523033 hasAuthorship W2080523033A5039274246 @default.
• W2080523033 hasAuthorship W2080523033A5046010426 @default.
• W2080523033 hasAuthorship W2080523033A5053698604 @default.
• W2080523033 hasAuthorship W2080523033A5058271076 @default.
• W2080523033 hasAuthorship W2080523033A5063117834 @default.
• W2080523033 hasAuthorship W2080523033A5085801546 @default.
• W2080523033 hasBestOaLocation W20805230331 @default.
• W2080523033 hasConcept C138816342 @default.
• W2080523033 hasConcept C144133560 @default.
• W2080523033 hasConcept C159110408 @default.
• W2080523033 hasConcept C162324750 @default.
• W2080523033 hasConcept C162853370 @default.
• W2080523033 hasConcept C17744445 @default.
• W2080523033 hasConcept C2780625559 @default.
• W2080523033 hasConcept C39549134 @default.
• W2080523033 hasConcept C50522688 @default.
• W2080523033 hasConcept C71924100 @default.
• W2080523033 hasConcept C83864248 @default.
• W2080523033 hasConceptScore W2080523033C138816342 @default.
• W2080523033 hasConceptScore W2080523033C144133560 @default.
• W2080523033 hasConceptScore W2080523033C159110408 @default.
• W2080523033 hasConceptScore W2080523033C162324750 @default.
• W2080523033 hasConceptScore W2080523033C162853370 @default.
• W2080523033 hasConceptScore W2080523033C17744445 @default.
• W2080523033 hasConceptScore W2080523033C2780625559 @default.
• W2080523033 hasConceptScore W2080523033C39549134 @default.
• W2080523033 hasConceptScore W2080523033C50522688 @default.
• W2080523033 hasConceptScore W2080523033C71924100 @default.
• W2080523033 hasConceptScore W2080523033C83864248 @default.
• W2080523033 hasIssue "S1" @default.
• W2080523033 hasLocation W20805230331 @default.
• W2080523033 hasLocation W20805230332 @default.
• W2080523033 hasLocation W20805230333 @default.
• W2080523033 hasLocation W20805230334 @default.
• W2080523033 hasLocation W20805230335 @default.
• W2080523033 hasOpenAccess W2080523033 @default.
• W2080523033 hasPrimaryLocation W20805230331 @default.
• W2080523033 hasRelatedWork W2011034454 @default.
• W2080523033 hasRelatedWork W2014680923 @default.
• W2080523033 hasRelatedWork W2119513903 @default.
• W2080523033 hasRelatedWork W2325300520 @default.
• W2080523033 hasRelatedWork W2595926391 @default.
• W2080523033 hasRelatedWork W2748952813 @default.
• W2080523033 hasRelatedWork W2899084033 @default.
• W2080523033 hasRelatedWork W3133812284 @default.
• W2080523033 hasRelatedWork W4285321855 @default.
• W2080523033 hasRelatedWork W2260511706 @default.
• W2080523033 hasVolume "10" @default.
• W2080523033 isParatext "false" @default.
• W2080523033 isRetracted "false" @default.
• W2080523033 magId "2080523033" @default.
• W2080523033 workType "article" @default.